Susquehanna International Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-574,600
| Closed | -$30.2M | – | 12145 |
|
|
2020
Q3 | $30.2M | Buy |
574,600
+542,600
| +1,696% | +$22.5M | 0.01% | 1171 |
|
|
2020
Q2 | $1.06M | Sell |
32,000
-58,900
| -65% | -$1.88M | ﹤0.01% | 5781 |
|
|
2020
Q1 | $2.47M | Buy |
90,900
+49,200
| +118% | +$1.37M | ﹤0.01% | 3599 |
|
|
2019
Q4 | $823K | Sell |
41,700
-50,700
| -55% | -$811K | ﹤0.01% | 5916 |
|
|
2019
Q3 | $1.2M | Buy |
92,400
+42,200
| +84% | +$510K | ﹤0.01% | 5304 |
|
|
2019
Q2 | $625K | Buy |
50,200
+30,000
| +149% | +$398K | ﹤0.01% | 6788 |
|
|
2019
Q1 | $294K | Sell |
20,200
-6,700
| -25% | -$85.6K | ﹤0.01% | 7252 |
|
|
2018
Q4 | $297K | Sell |
26,900
-20,100
| -43% | -$280K | ﹤0.01% | 7024 |
|
|
2018
Q3 | $1.24M | Sell |
47,000
-32,500
| -41% | -$879K | ﹤0.01% | 4822 |
|
|
2018
Q2 | $1.63M | Sell |
79,500
-7,800
| -9% | -$167K | ﹤0.01% | 4391 |
|
|
2018
Q1 | $1.58M | Buy |
87,300
+60,200
| +222% | +$1M | ﹤0.01% | 4356 |
|
|
2017
Q4 | $378K | Sell |
27,100
-58,500
| -68% | -$791K | ﹤0.01% | 7168 |
|
|
2017
Q3 | $1.58M | Sell |
85,600
-30,700
| -26% | -$513K | ﹤0.01% | 4353 |
|
|
2017
Q2 | $1.97M | Buy |
116,300
+57,400
| +97% | +$874K | ﹤0.01% | 3943 |
|
|
2017
Q1 | $786K | Sell |
58,900
-27,400
| -32% | -$429K | ﹤0.01% | 5637 |
|
|
2016
Q4 | $1.3M | Buy |
86,300
+4,300
| +5% | +$56.8K | ﹤0.01% | 4974 |
|
|
2016
Q3 | $959K | Buy |
82,000
+47,600
| +138% | +$560K | ﹤0.01% | 4887 |
|
|
2016
Q2 | $372K | Buy |
34,400
+22,200
| +182% | +$229K | ﹤0.01% | 6622 |
|
|
2016
Q1 | $113K | Sell |
12,200
-37,100
| -75% | -$399K | ﹤0.01% | 8378 |
|
|
2015
Q4 | $732K | Buy |
49,300
+39,300
| +393% | +$658K | ﹤0.01% | 6044 |
|
|
2015
Q3 | $164K | Sell |
10,000
-69,700
| -87% | -$1.43M | ﹤0.01% | 8859 |
|
|
2015
Q2 | $1.82M | Sell |
79,700
-202,700
| -72% | -$4.04M | ﹤0.01% | 4936 |
|
|
2015
Q1 | $4.29M | Buy |
282,400
+67,300
| +31% | +$874K | ﹤0.01% | 2966 |
|
|
2014
Q4 | $2.59M | Buy |
215,100
+97,800
| +83% | +$1.12M | ﹤0.01% | 3973 |
|
|
2014
Q3 | $1.33M | Sell |
117,300
-51,400
| -30% | -$586K | ﹤0.01% | 5368 |
|
|
2014
Q2 | $2.04M | Sell |
168,700
-160,200
| -49% | -$1.89M | ﹤0.01% | 4621 |
|
|
2014
Q1 | $3.83M | Buy |
328,900
+33,100
| +11% | +$561K | ﹤0.01% | 3279 |
|
|
2013
Q4 | $5.23M | Sell |
295,800
-32,200
| -10% | -$541K | ﹤0.01% | 2890 |
|
|
2013
Q3 | $4.72M | Buy |
328,000
+42,900
| +15% | +$657K | ﹤0.01% | 2821 |
|
|
2013
Q2 | $4.29M | Buy |
+285,100
| New | +$3.76M | ﹤0.01% | 2816 |
|
Susquehanna International Group's MNTA Position: Q4 2020 in Review
Susquehanna International Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 255,154 shares — an estimated $13.4M sold.
Susquehanna International Group first reported a position in MNTA in Q3 2013 and held it in 17 quarters. The position peaked at $13.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Susquehanna International Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Susquehanna International Group sold 255,154 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13.4M.
- Susquehanna International Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 17 quarters.
- Susquehanna International Group's Momenta Pharmaceuticals, Inc. position peaked at $13.4M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.